Kala Pharmaceuticals, Inc. (KALA)

USD 3.45

(-0.58%)

Revenue Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual revenue in 2023 was - USD , down -100.0% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down -100.0% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a annual revenue of 3.89 Million USD in annual revenue 2022, down -65.37% from previous year.
  • Kala Pharmaceuticals, Inc. reported a annual revenue of 11.24 Million USD in annual revenue 2021, up 76.67% from previous year.
  • Kala Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported a quarterly revenue of 70 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Revenue of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 - USD -100.0%
2022 3.89 Million USD -65.37%
2021 11.24 Million USD 76.67%
2020 6.36 Million USD 4.74%
2019 6.07 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 45 Thousand USD 0.0%

Peer Revenue Comparison of Kala Pharmaceuticals, Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 100.0%
China SXT Pharmaceuticals, Inc. 1.92 Million USD 100.0%
Embecta Corp. 1.12 Billion USD 100.0%
Pacira BioSciences, Inc. 674.97 Million USD 100.0%
PainReform Ltd. - USD NaN%
Sunshine Biopharma, Inc. 24.09 Million USD 100.0%
SCYNEXIS, Inc. 140.14 Million USD 100.0%
Journey Medical Corporation 79.18 Million USD 100.0%
Safety Shot Inc 202.67 Thousand USD 100.0%
Alpha Teknova, Inc. 36.68 Million USD 100.0%
Bright Green Corporation 401.49 Thousand USD 100.0%
Procaps Group, S.A. 409.92 Million USD 100.0%
Alvotech 91.43 Million USD 100.0%
ANI Pharmaceuticals, Inc. 486.81 Million USD 100.0%
Aquestive Therapeutics, Inc. 50.58 Million USD 100.0%
Cosmos Health Inc. 53.37 Million USD 100.0%
Dynavax Technologies Corporation 232.28 Million USD 100.0%
Esperion Therapeutics, Inc. 116.33 Million USD 100.0%
Intra-Cellular Therapies, Inc. 464.37 Million USD 100.0%
Sunshine Biopharma, Inc. 24.09 Million USD 100.0%
Theratechnologies Inc. 81.76 Million USD 100.0%
Harrow Health, Inc. 130.19 Million USD 100.0%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 100.0%
Biofrontera Inc. 34.07 Million USD 100.0%
DURECT Corporation 8.54 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 100.0%
Cronos Group Inc. 88.84 Million USD 100.0%
OptiNose, Inc. 70.98 Million USD 100.0%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 100.0%
RedHill Biopharma Ltd. 6.51 Million USD 100.0%
Organogenesis Holdings Inc. 433.14 Million USD 100.0%
Guardion Health Sciences, Inc. 12.24 Million USD 100.0%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 100.0%
Radius Health, Inc. 2.88 Billion USD 100.0%
Universe Pharmaceuticals INC 32.3 Million USD 100.0%
ProPhase Labs, Inc. 44.38 Million USD 100.0%
Phibro Animal Health Corporation 1.01 Billion USD 100.0%
Procaps Group S.A. 409.92 Million USD 100.0%
TherapeuticsMD, Inc. 1.3 Million USD 100.0%
Viatris Inc. 15.42 Billion USD 100.0%
Rockwell Medical, Inc. 83.61 Million USD 100.0%
Aytu BioPharma, Inc. 81 Million USD 100.0%
SIGA Technologies, Inc. 139.91 Million USD 100.0%
Tilray Brands, Inc. 788.94 Million USD 100.0%
Lifecore Biomedical, Inc. 128.26 Million USD 100.0%
Shineco, Inc. 9.8 Million USD 100.0%
PetIQ, Inc. 1.1 Billion USD 100.0%
Regencell Bioscience Holdings Limited - USD NaN%
Incannex Healthcare Limited 12 Thousand USD 100.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 100.0%
Alimera Sciences, Inc. 80.75 Million USD 100.0%
Silver Spike Investment Corp. 11.72 Million USD 100.0%
Assertio Holdings, Inc. 152.06 Million USD 100.0%
Shuttle Pharmaceuticals Holdings, Inc. - USD NaN%
Petros Pharmaceuticals, Inc. 5.82 Million USD 100.0%
Clever Leaves Holdings Inc. 17.41 Million USD 100.0%
Cyclo Therapeutics, Inc. 1.07 Million USD 100.0%
Avadel Pharmaceuticals plc 27.96 Million USD 100.0%
Hempacco Co., Inc. 4.04 Million USD 100.0%
Talphera, Inc. 651 Thousand USD 100.0%
Alvotech 91.43 Million USD 100.0%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 100.0%
Lantheus Holdings, Inc. 1.29 Billion USD 100.0%
Currenc Group, Inc. 53.25 Million USD 100.0%
Kamada Ltd. 144.75 Million USD 100.0%
Indivior PLC 1.09 Billion USD 100.0%
Evoke Pharma, Inc. 5.18 Million USD 100.0%
Flora Growth Corp. 76.07 Million USD 100.0%
Cyclo Therapeutics, Inc. 1.07 Million USD 100.0%
Evolus, Inc. 202.08 Million USD 100.0%
HUTCHMED (China) Limited 837.99 Million USD 100.0%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 100.0%
Akanda Corp. 2.16 Million USD 100.0%